Danaher (DHR) Provides Update On First Quarter 2021 Financial Performance

Danaher Corporation (NYSE: DHR) (the "Company") announced today that it expects first quarter 2021 core revenue growth to be above the high-end of the Company's previously communicated guidance range.

For the quarter ended April 2, 2021, the Company expects revenue growth to be approximately 57.0% and non-GAAP core revenue growth including Cytiva to be approximately 29.0%. The better-than-expected performance was broad-based across the portfolio, with particular strength in Life Sciences and Diagnostics.

As previously announced, Danaher will hold its earnings conference call for the first quarter 2021 on Thursday, April 22, 2021 at 8:00 a.m. ET.

You May Also Be Interested In

• Danaher (DHR) PT Raised to $271 at Baird
• Kaiser Aluminum (KALU) Tops Q1 EPS by 42c
• Ball Corporation (BALL) Raises Dividend, Enters 40M Share Buyback, Announces Management Changes